$A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab$

A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab

Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving protease (ADAMTS13) due to autoantibodies that are...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	SAMJ: South African Medical Journal 2016-07, Vol.106 (7), p.689-691
Hauptverfasser:	Kirui, N., Sokwala, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Africa South of the Sahara Diagnosis Drug therapy Health Care Sciences & Services Health Policy & Services Humans Immunologic Factors - therapeutic use Male Medical Ethics Medicine, General & Internal Medicine, Legal Medicine, Research & Experimental Methods Middle Aged Patient outcomes Plasmapheresis Purpura, Thrombotic Thrombocytopenic - diagnosis Purpura, Thrombotic Thrombocytopenic - therapy Rituximab - therapeutic use Thrombocytopenic purpura
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!